查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
失眠治疗全球市场规模研究与预测，按产品（药物、设备），按销售渠道（处方药、非处方药 (OTC)），按地区，2022-2029 年
市场调查报告书
商品编码
1251590

失眠治疗全球市场规模研究与预测，按产品（药物、设备），按销售渠道（处方药、非处方药 (OTC)），按地区，2022-2029 年

Global Insomnia Therapeutics Market Size study & Forecast, by Product (Drugs, Device) by Sales Channel (Prescription, Over-the-Counter (OTC))and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球失眠治疗市场价值约为 28 亿美元，预计在 2022-2029 年预测期内将以超过 5.3% 的强劲增长率增长。

失眠药物是预防失眠的有效疗法。 失眠是一种睡眠障碍，导致入睡困难和难以入睡。 这是一种非常常见的疾病，影响着很多人。 这种疾病有多种原因，包括压力、睡眠不足、不良睡眠习惯和焦虑。 它还会影响心理健康、工作绩效和个人生活质量。 此外，个人压力的增加以及 COVID-19 对失眠市场的积极影响正在推动失眠药物市场。

由于多种原因，全球人口压力水平不断增加导致失眠，进一步推动了失眠药物市场。 例如，在 2022 年，50% 的受访者表示他们的压力会比前一年更大。 而在 2019 年，这一比例仅为 38%。 压力来源包括工作量、家庭问题、个人医疗保健和个人心理健康问题。 由于不同的原因，所有年龄组都受到这种睡眠障碍的影响。 大流行 COVID-19 对失眠市场产生了积极影响。 由于失业和不可预见的情况，人们承受着压力。 此类致命的生活事件导致市场上对失眠药物的需求激增。 约 67% 的受访者表示，他们在 2020 年全球大流行期间经历了更高水平的压力。 此外，不断增加的个人繁忙日程以及更好的失眠药物和配方的不断进步推动了需求。 然而，失眠药物的高成本将阻碍整个 2022-2029 年预测期内的市场增长。

全球失眠药物市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和拉丁美洲其他地区。 北美在失眠药物市场占有压倒性的份额，占有 54% 的份额。 老年人口的增加和失眠症的高患病率正在推动失眠药物市场。 主要市场参与者增加研发投资和频繁推出产品的创新在市场需求中发挥着重要作用。 亚太地区预计将成为增长最快的地区，因为压力和工作超负荷会影响睡眠并导致失眠。 对睡眠障碍治疗的认识不断提高正在推动市场需求。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年全球和细分市场估计和预测
    • 2019-2029 年按地区分列的失眠药物市场
    • 失眠治疗市场，副产品，2019-2029
    • 失眠治疗市场，按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球失眠治疗市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章全球失眠药物市场动态

  • 失眠治疗市场影响分析 (2019-2029)
    • 市场驱动因素
      • 压力增加
      • COVID-19 的积极影响
    • 市场挑战
      • 失眠药物的高成本
    • 市场机会
      • 制定的进展
      • 增加繁忙的工作日程

第 4 章全球失眠药物市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 主要投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球失眠治疗市场：按产品分类

  • 市场概况
  • 全球失眠药物市场：按产品、按性能 - 潜力分析
  • 全球失眠药物市场：2019-2029 年按产品估算和预测
  • 失眠治疗市场细分分析
    • 药物
    • 设备

第 7 章全球失眠药物市场：按分销渠道

  • 市场概况
  • 全球失眠药物市场：销售渠道的性能潜力分析
  • 全球失眠药物市场：估计和预测（按销售渠道）2019-2029
  • 失眠治疗市场细分分析
    • 处方
    • 场外交易 (OTC)

第 8 章全球失眠药物市场：区域分析

  • 失眠药物市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按产品估算和预测
      • 按销售渠道估算和预测，2019 年至 2029 年
    • 加拿大
  • 欧洲失眠药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区失眠治疗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲的失眠药物市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 武田製药有限公司；
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概述
      • 近期趋势
    • Idorsia Pharmaceuticals Ltd
    • Eisai Co., Ltd.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi S.A.
    • Electromedical Products International, Inc.
    • Paratek Pharmaceuticals, Inc.
    • Sumitomo Pharma Co., Ltd.

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Insomnia Therapeutics Market is valued at approximately USD 2.8 billion in 2021and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2022-2029.Insomnia Therapeutics is the treatment effective in preventing Insomnia. It is a sleep disorder that creates difficulty for the individual to fall or stay asleep. It is a very common disease prevailing these days and affecting a number of populations. There are several reasons for this disorder such as stress, poor sleep schedules, bad sleeping habits, anxiety and so on. It also affects mental health, work performance and quality of individual life. Additionally, increasing incidences of stress among individuals and the positive impact of COVID-19 on the insomnia market are driving the market for Insomnia Therapeutics.

The increasing stress levels among the global population due to several reasons lead to insomnia further driving the market for Insomnia Therapeutics. For instance, in 2022 50% of respondents were feeling more stressed than in the previousyear. In 2019 the percentage was just 38%. The stress can be due to workload, family issues, personal health care, and individual mental health. All age groups were affected due to this sleep disorder due to different reasons. The pandemic COVID-19 laid a positive impact on the Insomnia market. People suffered from stress due to job losses and unexpected situations. Such a deadly life event surged the demand for insomnia therapeutics in the market. Around 67% of respondents experienced higher levelsof stress during the pandemic globally in 2020. Moreover, the constant rise in hectic schedules of individuals, and continuous advancements and formulations in better insomnia treatment methods boosted the demand. However, the high cost of Insomnia Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Insomnia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for Insomnia therapeutics with a share of 54%. The growing geriatricc population and high prevalence of insomnia in this population is driving the market for Insomnia Therapeutics. The growing investments of key market players in R&D and innovations through frequent product launches play a major role in market demand. Asia-Pacific is expected to be the fastest-growing region due to increased stress and work schedules affecting sleep among the population is leading to insomnia disorders. The rising awareness to cure for sleep disorders is boosting the market demand.

Major market players included in this report are:

  • Takeda Pharmaceutical Company Ltd.;
  • Idorsia Pharmaceuticals Ltd
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Electromedical Products International, Inc.
  • Paratek Pharmaceuticals, Inc.
  • Sumitomo Pharma Co., Ltd.

Recent Developments in the Market:

  • In May 2022, QUVIVIQ a medication to treat adult patients with insomnia launched by Idorsia Ltd received approval from European Commission. The symptoms should be for at least 3 months and impact daytime working.
  • In June 2021, DAYVIGO was launched by Eisai Co., Ltd., a global leader in life science products. This launch was to treat insomnia in adults. It was also approved by U.S. Food and Drug Administration (FDA).

Global Insomnia Therapeutics Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, Sales Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByProduct:

  • Drugs
  • Device

By Sales Channel:

  • Prescription
  • Over-the-Counter (OTC)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Insomnia Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Insomnia Therapeutics Market, by Product,2019-2029 (USD Billion)
    • 1.2.3. Insomnia Therapeutics Market, by Sales Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Insomnia Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Insomnia Therapeutics Market Dynamics

  • 3.1. Insomnia Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Stress.
      • 3.1.1.2. Positive Impact of COVID-19.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Insomnia Therapeutics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation.
      • 3.1.3.2. Rising hectic work schedule.

Chapter 4. Global Insomnia Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Insomnia Therapeutics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Insomnia Therapeutics Market by Product, Performance - Potential Analysis
  • 6.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Device

Chapter 7. Global Insomnia Therapeutics Market, by Sales Channel

  • 7.1. Market Snapshot
  • 7.2. Global Insomnia Therapeutics Market by Sales Channel, Performance - Potential Analysis
  • 7.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Sales Channel 2019-2029 (USD Billion)
  • 7.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Prescription
    • 7.4.2. Over-the-Counter (OTC)

Chapter 8. Global Insomnia Therapeutics Market, Regional Analysis

  • 8.1. Insomnia Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Insomnia Therapeutics Market
    • 8.2.1. U.S.Insomnia Therapeutics Market
      • 8.2.1.1. Productbreakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Sales Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. CanadaInsomnia Therapeutics Market
  • 8.3. Europe Insomnia Therapeutics Market Snapshot
    • 8.3.1. U.K. Insomnia Therapeutics Market
    • 8.3.2. Germany Insomnia Therapeutics Market
    • 8.3.3. France Insomnia Therapeutics Market
    • 8.3.4. Spain Insomnia Therapeutics Market
    • 8.3.5. Italy Insomnia Therapeutics Market
    • 8.3.6. Rest of EuropeInsomnia Therapeutics Market
  • 8.4. Asia-PacificInsomnia Therapeutics Market Snapshot
    • 8.4.1. China Insomnia Therapeutics Market
    • 8.4.2. India Insomnia Therapeutics Market
    • 8.4.3. JapanInsomnia Therapeutics Market
    • 8.4.4. Australia Insomnia Therapeutics Market
    • 8.4.5. South Korea Insomnia Therapeutics Market
    • 8.4.6. Rest of Asia PacificInsomnia Therapeutics Market
  • 8.5. Latin America Insomnia Therapeutics Market Snapshot
    • 8.5.1. Brazil Insomnia Therapeutics Market
    • 8.5.2. MexicoInsomnia Therapeutics Market
  • 8.6. Rest of The World Insomnia Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Takeda Pharmaceutical Company Ltd.;
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. ProductSummary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Idorsia Pharmaceuticals Ltd
    • 9.2.3. Eisai Co., Ltd.
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Teva Pharmaceutical Industries Ltd.
    • 9.2.7. Sanofi S.A.
    • 9.2.8. Electromedical Products International, Inc.
    • 9.2.9. Paratek Pharmaceuticals, Inc.
    • 9.2.10. Sumitomo Pharma Co., Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Insomnia Therapeutics Market, report scope
  • TABLE 2. Global Insomnia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Insomnia Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Insomnia Therapeutics Market estimates & forecasts by Sales Channel 2019-2029 (USD Billion)
  • TABLE 5. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPACInsomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Insomnia Therapeutics Market, research methodology
  • FIG 2. Global Insomnia Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Insomnia Therapeutics Market, key trends 2021
  • FIG 5. Global Insomnia Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Insomnia Therapeutics Market, porters 5 force model
  • FIG 7. Global Insomnia Therapeutics Market, pest analysis
  • FIG 8. Global Insomnia Therapeutics Market, value chain analysis
  • FIG 9. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Insomnia Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 16. Europe Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 18. Latin America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 19. Global Insomnia Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable